Investment Summary |
|
|---|---|
| Date | 2011-02-23 |
| Target | Caraco Pharmaceutical Laboratories |
| Sector | Life Science |
| Investor(s) | Sun Pharma |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1983 |
| Sector | Life Science |
| Employees | 43,000 |
| Revenue | 520.4B INR (2025) |
Sun Pharma is a specialty generic pharmaceutical company. Products are sold through drug stores, mass merchants, grocery stores, and gift/specialty stores. Sun Pharma was founded in 1983 and is based in Mumbai, Maharashtra.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 15 |
| Sector: Life Science M&A | 3 of 10 |
| Type: Stake Purchase M&A Deals | 5 of 5 |
| State: Michigan M&A | 2 of 2 |
| Country: United States M&A | 2 of 7 |
| Year: 2011 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-05-21 |
Taro Pharmaceutical Industries
Haifa Bay, Israel Taro Pharmaceutical Industries is a manufacturer and developer of generic drugs and pharmaceutical components. Taro Pharmaceutical Industries was founded in 1950 and is based in Haifa, Israel. |
Buy | $454M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-20 |
DUSA Pharmaceuticals
Wilmington, Massachusetts, United States DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. |
Buy | $230M |
